Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Final Guidance on MFS in nmCRPC Released by the FDA,

The use of metastases-free survival as an end point for clinical trials in non-metastatic, castration-resistance prostate cancer has been given finalized …, The use of metastases-free survival as an end point for clinical trials in non-metastatic, castration-resistance prostate cancer has been given finalized …, Read More

Scroll to Top